Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mazzei

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Biochemical Pharmacology|September 15, 1987
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cellsE Mini, T Mazzei, M Coronnello, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Perioperative chemotherapy in the treatment of carcinoma of the uterine cervixF Gasparri, P Periti, G Scarselli, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporinE Mini, T Mazzei, P Periti, et al.
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Do different susceptibility breakpoints affect the selection of antimicrobials for treatment of uncomplicated cystitis?G C Schito, L Gualco, K G Naber, et al.
Anti-Cancer Drugs|July 18, 2000
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotidesM Morganti, M Coronnello, B Caciagli, et al.
Oncology Research|November 8, 2001
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivityM Coronnello, G Marcon, S Carotti, et al.
Investigational New Drugs|January 1, 1985
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancerP Periti, G R della Cuna, F Pannuti, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
Pharmacokinetics of azithromycin in patients with impaired hepatic functionT Mazzei, C Surrenti, A Novelli, et al.
Anti-Cancer Drug Design|February 25, 1998
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatinP Calamai, S Carotti, A Guerri, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patientsT Mazzei, A Novelli, S Esposito, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Biochemical Pharmacology|September 15, 1987
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cellsE Mini, T Mazzei, M Coronnello, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Perioperative chemotherapy in the treatment of carcinoma of the uterine cervixF Gasparri, P Periti, G Scarselli, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporinE Mini, T Mazzei, P Periti, et al.
Journal of Chemotherapy (Florence, Italy)|December 3, 2010
Do different susceptibility breakpoints affect the selection of antimicrobials for treatment of uncomplicated cystitis?G C Schito, L Gualco, K G Naber, et al.
Anti-Cancer Drugs|July 18, 2000
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotidesM Morganti, M Coronnello, B Caciagli, et al.
Oncology Research|November 8, 2001
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivityM Coronnello, G Marcon, S Carotti, et al.
Investigational New Drugs|January 1, 1985
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancerP Periti, G R della Cuna, F Pannuti, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
Pharmacokinetics of azithromycin in patients with impaired hepatic functionT Mazzei, C Surrenti, A Novelli, et al.
Anti-Cancer Drug Design|February 25, 1998
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatinP Calamai, S Carotti, A Guerri, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2000
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patientsT Mazzei, A Novelli, S Esposito, et al.
Pageof 11